Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter Lang

Showing results (211-220 of 312) with videos related to

Pageof 32
Sort By:
Cancer Genetics|January 19, 2023
Rare and potentially fatal - Cytogenetically cryptic TNIP1::PDGFRB and PCM1::FGFR1 fusion leading to myeloid/lymphoid neoplasms with eosinophilia in childrenAnn-Cathrine Berking, Tim Flaadt, Yvonne Lisa Behrens, et al.
Blood Cells, Molecules & Diseases|September 22, 2007
Retransplantation with stem cells from mismatched related donors after graft rejection in pediatric patientsPeter Lang, Ingo Mueller, Johann Greil, et al.
Bone Marrow Transplantation|August 22, 2019
Ex vivo expansion of autologous, donor-derived NK-, γδT-, and cytokine induced killer (CIK) cells post haploidentical hematopoietic stem cell transplantation results in increased antitumor activityPatrick Schlegel, Anne-Marie Lang, Marie Matela, et al.
Blood Advances|February 3, 2026
Allogeneic HSCT for consolidation in pediatric refractory or relapsed ALK-positive anaplastic large cell lymphomaFabian Knörr, Martin Zimmermann, Peter Bader, et al.
International Journal of Radiation Oncology, Biology, Physics|December 30, 2018
Immunosuppressive Total Nodal Irradiation-Based Reconditioning Regimens After Graft Rejection or Graft Failure in Pediatric Patients Treated With Myeloablative Allogeneic Hematopoietic Cell TransplantationDaniel Wegener, Peter Lang, Frank Paulsen, et al.
British Journal of Haematology|June 25, 2016
Treatment of graft failure with TNI-based reconditioning and haploidentical stem cells in paediatric patientsHeiko-Manuel Teltschik, Frank Heinzelmann, Bernd Gruhn, et al.
Stem Cells and Development|April 17, 2020
Longtime Outcome After Intraosseous Application of Autologous Mesenchymal Stromal Cells in Pediatric Patients and Young Adults with Avascular Necrosis After Steroid or ChemotherapyMichaela Döring, Torsten Kluba, Karin Melanie Cabanillas Stanchi, et al.
Blood|November 1, 2014
Both mature KIR+ and immature KIR- NK cells control pediatric acute B-cell precursor leukemia in NOD.Cg-Prkdcscid IL2rgtmWjl/Sz miceAyline Kübler, Jeanette Woiterski, Kai-Erik Witte, et al.
British Journal of Haematology|June 29, 2006
Safe adoptive transfer of virus-specific T-cell immunity for the treatment of systemic adenovirus infection after allogeneic stem cell transplantationTobias Feuchtinger, Susanne Matthes-Martin, Celine Richard, et al.
International Journal of Cancer|March 26, 2013
Engraftment of low numbers of pediatric acute lymphoid and myeloid leukemias into NOD/SCID/IL2Rcγnull mice reflects individual leukemogenecity and highly correlates with clinical outcomeJeanette Woiterski, Martin Ebinger, Kai E Witte, et al.
Pageof 32

Showing results (211-220 of 312) with videos related to

Sort By:
Pageof 32
Cancer Genetics|January 19, 2023
Rare and potentially fatal - Cytogenetically cryptic TNIP1::PDGFRB and PCM1::FGFR1 fusion leading to myeloid/lymphoid neoplasms with eosinophilia in childrenAnn-Cathrine Berking, Tim Flaadt, Yvonne Lisa Behrens, et al.
Blood Cells, Molecules & Diseases|September 22, 2007
Retransplantation with stem cells from mismatched related donors after graft rejection in pediatric patientsPeter Lang, Ingo Mueller, Johann Greil, et al.
Bone Marrow Transplantation|August 22, 2019
Ex vivo expansion of autologous, donor-derived NK-, γδT-, and cytokine induced killer (CIK) cells post haploidentical hematopoietic stem cell transplantation results in increased antitumor activityPatrick Schlegel, Anne-Marie Lang, Marie Matela, et al.
Blood Advances|February 3, 2026
Allogeneic HSCT for consolidation in pediatric refractory or relapsed ALK-positive anaplastic large cell lymphomaFabian Knörr, Martin Zimmermann, Peter Bader, et al.
International Journal of Radiation Oncology, Biology, Physics|December 30, 2018
Immunosuppressive Total Nodal Irradiation-Based Reconditioning Regimens After Graft Rejection or Graft Failure in Pediatric Patients Treated With Myeloablative Allogeneic Hematopoietic Cell TransplantationDaniel Wegener, Peter Lang, Frank Paulsen, et al.
British Journal of Haematology|June 25, 2016
Treatment of graft failure with TNI-based reconditioning and haploidentical stem cells in paediatric patientsHeiko-Manuel Teltschik, Frank Heinzelmann, Bernd Gruhn, et al.
Stem Cells and Development|April 17, 2020
Longtime Outcome After Intraosseous Application of Autologous Mesenchymal Stromal Cells in Pediatric Patients and Young Adults with Avascular Necrosis After Steroid or ChemotherapyMichaela Döring, Torsten Kluba, Karin Melanie Cabanillas Stanchi, et al.
Blood|November 1, 2014
Both mature KIR+ and immature KIR- NK cells control pediatric acute B-cell precursor leukemia in NOD.Cg-Prkdcscid IL2rgtmWjl/Sz miceAyline Kübler, Jeanette Woiterski, Kai-Erik Witte, et al.
British Journal of Haematology|June 29, 2006
Safe adoptive transfer of virus-specific T-cell immunity for the treatment of systemic adenovirus infection after allogeneic stem cell transplantationTobias Feuchtinger, Susanne Matthes-Martin, Celine Richard, et al.
International Journal of Cancer|March 26, 2013
Engraftment of low numbers of pediatric acute lymphoid and myeloid leukemias into NOD/SCID/IL2Rcγnull mice reflects individual leukemogenecity and highly correlates with clinical outcomeJeanette Woiterski, Martin Ebinger, Kai E Witte, et al.
Pageof 32